AIY Combinator8 months ago
BillionToOne Goes Public, The Startup That Made Genetic Testing Universal
3 min read
BillionToOne went public as Y Combinator's fourth publicly traded biotech company. The startup's fetal genetic test screens 1 in 11 babies born in the U.S. The test sequences fetal DNA fragments from maternal blood, replacing invasive amniocentesis. The company launched a commercial test within two years on seed funding.
Level
Hype check
Tap to vote and see what everyone thinks.